What is the CVR number of KARL STORZ ENDOSKOPI DANMARK A/S?

KARL STORZ ENDOSKOPI DANMARK A/S is registered with CVR / Virk under CVR 20284390.

What is the revenue of KARL STORZ ENDOSKOPI DANMARK A/S?

KARL STORZ ENDOSKOPI DANMARK A/S reported revenue of DKK 19,1M in 2024.

KARL STORZ ENDOSKOPI DANMARK A/S employs 16 people as of the latest annual report.

Jens Bo Hvidt is Management of KARL STORZ ENDOSKOPI DANMARK A/S, in role since 1998.

Sybill Renate Storz-Reling chairs the board of KARL STORZ ENDOSKOPI DANMARK A/S, in role since 1998.

KARL STORZ ENDOSKOPI DANMARK A/S's registered address is Skovlytoften 33.

A/SActive

CVR 20284390Skovlytoften 33, 2840 HolteWholesale of pharmaceutical and medical goods · NACE 4646Est. 199716 employees

Actively employed in the business

Name	Role	Member since
Current (1)
MP Michael Persson Chief Executive Officer	Chief Executive Officer	2025
Former (8)
JB Jens Bo Hvidt Management	Management	1998 – 1998
VC Victor Christoffersen Management	Management	1997 – 1998
ÅS Åge Schultz Management	Management	1998 – 2002
MR Morten Ralbjerg Chief Executive Officer	Chief Executive Officer	2007 – 2024
KH Kiyoshi Hyman Chief Executive Officer	Chief Executive Officer	2025 – 2025
CA Carlofelice Augusto Cesare Boella Management	Management	2002 – 2002
NJ Nis Jørn Bennetzen Audit	Audit	1997 – 1998
LW Lone Wimmelmann Rørvig Chief Executive Officer	Chief Executive Officer	2002 – 2007

Non-executive oversight

Name	Role	Member since
Current (3)
KS Karl-Christian Storz	Board of Directors	1998
SR Stefan Reinel	Board of Directors	2004
SR Sybill Renate Storz	Board of Directors	1997
Former (4)
SB Sebastian Benjamin Bahn Christoffersen	Board of Directors	1997 – 1998
SR Sybill Renate Storz-Reling	Chairman	1998 – 1998
HM Helen Mimi Janniche	Board of Directors	1997 – 1998
TV Torsten Valdemar Hvidt	Board of Directors	1998 – 2004

As of last annual report

Shareholder	Type	Ownership	Votes	Since
KARL STORZ SE & Co. KG	Individual	100%	100%	2006

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.